Viewing Study NCT04182360

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-25 @ 2:12 AM
Ignite Modification Date: 2026-02-25 @ 8:26 PM
Study NCT ID: NCT04182360
Status: COMPLETED
Last Update Posted: 2023-07-06
First Post: 2019-11-27
Is Gene Therapy: True
Has Adverse Events: False
Brief Title: Carbetocin at Elective Cesarean Deliveries: A Dose-finding Study in Women With Twin Pregnancy.
Sponsor: Samuel Lunenfeld Research Institute, Mount Sinai Hospital
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Postpartum Hemorrhage View
None Twin View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Pregnancy View
None Twins View
None Postpartum hemorrhage View
None carbetocin View
None uterotonic View
None cesarean delivery View